Guest guest Posted April 21, 2009 Report Share Posted April 21, 2009 Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients " This study marks an important milestone in the development of our ToleroMune anti-allergy technology, as it extends our target patient group to those with more serious allergies that can result in asthma attacks, " said Steve , Circassia's CEO. http://news.prnewswire.com/DisplayReleaseContent.aspx?ACCT=104 & STORY=/www/story/\ 04-21-2009/0005009477 & EDATE= Alana Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.